Fate Therapeutics (FATE) PT Lowered to $11 at Canaccord Genuity

February 27, 2024 8:17 AM EST Send to a Friend
Canaccord Genuity analyst Bill Maughan ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login